Other Stories

Moderna to supply 100 to 125 million COVID-19 vaccine doses globally in Q1 of 2021 Updated: 2020-12-04 13:18:21 KST

Moderna says it expects to have 100 million to 125 million doses of its COVID-19 vaccine available across the globe in the first quarter of 2021.
According to Reuters, the company said on Thursday that 85 million to 100 million of doses would be available in the U.S., and 15 million to 25 million would be sent to other countries around the world.
The vaccine requires two doses given one month apart.
But another U.S. drugmaker Pfizer has cut in half its production target for vaccine doses for this year.
Pfizer had originally planned to ship 100 million vaccine doses this year, but the company now says it anticipates producing just 50 million.
This is due to challenges in supply chain for the raw materials used in its vaccine.
The company said the scale-up of the raw material supply chain took longer than originally anticipated, and later-than-expected results from its clinical trial caused the company to lower its target.
But the company said its full scale production lines in the U.S. and Europe are complete, and it's confident it'll be able to supply the targeted doses.
The company is expected to roll out 1.3 billion doses in 2021.
Its vaccine requires two doses given three weeks apart.
Kim Jae-hee, Arirang News.
Reporter : jhee@arirang.com
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.